PM

Paul MacLeman

Island Pharmaceuticals Limited | Executive Chairman, Executive Director
Mr MacLeman has more than 25 years of experience across all phases of the life sciences sector. With a career-spanning veterinary practice, pharmaceutical development and manufacturing, biotechnology, diagnostics and finance, Paul has expertise in capital management, business development, technology commercialisation and sales & marketing globally. Paul has launched products using in-house and outsourced sales staff in Australia and the US. He has founded life sciences start-ups in the biologics area and worked in investment banking focusing on the analysis and financing of technology companies. Paul has previously served as Chairman, Director or Managing Director/CEO of several VC funded, ASX, NASDAQ, CSE and TSX listed companies and has driven a number of IPOs. Paul Chaired the Industry Review Committee for the Pharmaceutical Manufacturing National Training Package for the AISC for 10 years prior to the establishment of the new Jobs and Skills Councils and advises the new formed Manufacturing Industry Skills Alliance. He is also an advisor to PharmaVentures plc. (Oxford, UK) and serves on a number of other NFP and government advisory groups. He currently Chairs or is a Non-Executive Director of a number of public unlisted and private companies.

Companies and Roles

Company
Title
Tenure
Since
ILA
Island Pharmaceuticals Limited
  • Executive Chairman
  • Executive Director
4yrsMay 2020
1AD
AdAlta Limited
  • Non-Executive Chairman
  • Non-Executive Director
4yrs, 8mthOct 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ILA
Island Pharmaceuticals Limited
30/04/241118,62533,572N/A
1AD
AdAlta Limited
19/12/23366,363106,6075,855,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ILA
Island Pharmaceuticals Limited
30/04/24
Expiry
2,325,000$0.053$123,225Options expired
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
33,572$0.060$2,014Rights issue
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
33,572$0.060$2,014Rights issue
1AD
AdAlta Limited
19/12/23
Issued
2,800,000$0.013$35,347Issue of options
1AD
AdAlta Limited
29/11/21
Issued
3,055,000$0.082$250,510Issue of options